These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 17636596

  • 1. WITHDRAWN: Vaccines for preventing malaria.
    Graves P, Gelband H.
    Cochrane Database Syst Rev; 2007 Jul 18; 2003(4):CD000129. PubMed ID: 17636596
    [Abstract] [Full Text] [Related]

  • 2. Vaccines for preventing malaria.
    Graves P, Gelband H.
    Cochrane Database Syst Rev; 2003 Jul 18; (1):CD000129. PubMed ID: 12535387
    [Abstract] [Full Text] [Related]

  • 3. Vaccines for preventing malaria.
    Graves P, Gelband H.
    Cochrane Database Syst Rev; 2000 Jul 18; (2):CD000129. PubMed ID: 10796492
    [Abstract] [Full Text] [Related]

  • 4. Vaccines for preventing malaria (SPf66).
    Graves P, Gelband H.
    Cochrane Database Syst Rev; 2006 Apr 19; 2006(2):CD005966. PubMed ID: 16625647
    [Abstract] [Full Text] [Related]

  • 5. Vaccines for preventing malaria (blood-stage).
    Graves P, Gelband H.
    Cochrane Database Syst Rev; 2006 Oct 18; 2006(4):CD006199. PubMed ID: 17054281
    [Abstract] [Full Text] [Related]

  • 6. Vaccines for preventing malaria (pre-erythrocytic).
    Graves P, Gelband H.
    Cochrane Database Syst Rev; 2006 Oct 18; 2006(4):CD006198. PubMed ID: 17054280
    [Abstract] [Full Text] [Related]

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 8. Efficacy trial of malaria vaccine SPf66 in Gambian infants.
    D'Alessandro U, Leach A, Drakeley CJ, Bennett S, Olaleye BO, Fegan GW, Jawara M, Langerock P, George MO, Targett GA.
    Lancet; 1995 Aug 19; 346(8973):462-7. PubMed ID: 7637479
    [Abstract] [Full Text] [Related]

  • 9. Humoral immune responses during a malaria vaccine trial in Tanzanian infants.
    Galindo CM, Acosta CJ, Schellenberg D, Aponte JJ, Roca A, Oettli A, Urassa H, Armstrong Schellenberg J, Kahigwa E, Ascaso C, Mshinda H, Lwilla F, Vidal J, Menendez C, Tanner M, Alonso PL.
    Parasite Immunol; 2000 Sep 19; 22(9):437-43. PubMed ID: 10972850
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The development of malaria vaccines: SPf66--what next?
    Tanner M, Alonso PL.
    Schweiz Med Wochenschr; 1996 Jul 09; 126(27-28):1210-5. PubMed ID: 8766632
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in Tanzania.
    Acosta CJ, Galindo CM, Schellenberg D, Aponte JJ, Kahigwa E, Urassa H, Schellenberg JR, Masanja H, Hayes R, Kitua AY, Lwilla F, Mshinda H, Menendez C, Tanner M, Alonso PL.
    Trop Med Int Health; 1999 May 09; 4(5):368-76. PubMed ID: 10402973
    [Abstract] [Full Text] [Related]

  • 14. Reduction in the mean number of Plasmodium falciparum genotypes in Gambian children immunized with the malaria vaccine SPf66.
    Haywood M, Conway DJ, Weiss H, Metzger W, D'Alessandro U, Snounou G, Targett G, Greenwood B.
    Trans R Soc Trop Med Hyg; 1999 Feb 09; 93 Suppl 1():65-8. PubMed ID: 10450429
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of SPf66 malaria vaccine efficacy in Brazil.
    Urdaneta M, Prata A, Struchiner CJ, Tosta CE, Tauil P, Boulos M.
    Am J Trop Med Hyg; 1998 Mar 09; 58(3):378-85. PubMed ID: 9546423
    [Abstract] [Full Text] [Related]

  • 16. Duration of protection and age-dependence of the effects of the SPf66 malaria vaccine in African children exposed to intense transmission of Plasmodium falciparum.
    Alonso PL, Smith TA, Armstrong-Schellenberg JR, Kitua AY, Masanja H, Hayes R, Hurt N, Font F, Menendez C, Kilama WL, Tanner M.
    J Infect Dis; 1996 Aug 09; 174(2):367-72. PubMed ID: 8699068
    [Abstract] [Full Text] [Related]

  • 17. Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria.
    al-Yaman F, Genton B, Anders R, Taraika J, Ginny M, Mellor S, Alpers MP.
    Parasite Immunol; 1995 Sep 09; 17(9):493-501. PubMed ID: 8552419
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group.
    Nosten F, Luxemburger C, Kyle DE, Ballou WR, Wittes J, Wah E, Chongsuphajaisiddhi T, Gordon DM, White NJ, Sadoff JC, Heppner DG.
    Lancet; 1996 Sep 14; 348(9029):701-7. PubMed ID: 8806288
    [Abstract] [Full Text] [Related]

  • 20. Immune responses to Plasmodium falciparum antigens during a malaria vaccine trial in Tanzanian children.
    Alonso PL, Lopez MC, Bordmann G, Smith TA, Aponte JJ, Weiss NA, Urassa H, Armstrong-Schellenberg JR, Kitua AY, Masanja H, Thomas MC, Oettli A, Hurt N, Hayes R, Kilama WL, Tanner M.
    Parasite Immunol; 1998 Feb 14; 20(2):63-71. PubMed ID: 9572049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.